Research Articles | Page 100 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
The diagnosis and treatment of aplastic anemia: a review Apr 2015 Int J Hematol aplastic anemia
The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes Jan 2012 PLoS One myelodysplastic syndromes (MDS)
The difficulty to define progression patterns in patients with early stage myelodysplastic syndromes and deletion 5q-New prognostic markers are needed Dec 2013 Leuk Res myelodysplastic syndromes (MDS)
The dysfunction of platelets in paroxysmal nocturnal hemoglobinuria Jul 2016 Thromb Res paroxysmal nocturnal hemoglobinuria (PNH)
The Effect of Decitabine Dose Modification and Myelosuppression on Response and Survival in Patients With Myelodysplastic Syndromes May 2014 Leuk Lymphoma myelodysplastic syndromes (MDS)
The Effect of Respiratory Viral Infections on Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria May 2023 International Journal of Molecular Sciences paroxysmal nocturnal hemoglobinuria (PNH)
The Efficacy of Current Prognostic Models in Predicting Outcome of Patients with Myelodysplastic Syndromes at the Time of Hypomethylating Agent Failure Mar 2016 Haematologica myelodysplastic syndromes (MDS)
The Evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes. Mar 2013 Hematology myelodysplastic syndromes (MDS)
The evolution of epigenetic therapy in myelodysplastic syndromes and acute myeloid leukemia Jan 2021 Seminars in Hematology acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
The evolving role of next generation sequencing in myelodysplastic syndromes Oct 2019 British Journal of Haematology myelodysplastic syndromes (MDS)
Share with addtoany.com.